Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS10018658
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018658
Fusion event
HBV-SORCS2 integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Nontumor
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2017
PubMed ID
29212479
Virus Sequence
Virus name
HBV
Reference genome
NC_003977
Start
1779
Integrated sequence
CAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGG| |AGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGC
Host Sequence
Chromosome
chr4
Cytoband
p16.1
Reference genome
GRCh37.55
Start
7386652/7384925 (Hg38)
End
7386652/7384925 (Hg38)
Location type
Intron1
Fragile sites / regions
FRA4A
Target gene
SORCS2
miRNAs that regulate target gene
hsa-mir-1274b
;
hsa-mir-23b-3p
;
hsa-mir-6818-5p
;
hsa-mir-1273e
;
hsa-mir-636
;
hsa-mir-520f-3p
;
hsa-mir-302c-3p
;
hsa-mir-520e
;
hsa-mir-520d-3p
;
hsa-mir-520c-3p
;
hsa-mir-520b
;
hsa-mir-520a-3p
;
hsa-mir-373-3p
;
hsa-mir-372-3p
;
hsa-mir-302e
;
hsa-mir-302d-3p
;
hsa-mir-302b-3p
;
hsa-mir-302a-3p
;
hsa-mir-93-5p
;
hsa-mir-526b-3p
;
hsa-mir-519d-3p
;
hsa-mir-20b-5p
;
hsa-mir-20a-5p
;
hsa-mir-17-5p
;
hsa-mir-106b-5p
;
hsa-mir-106a-5p
;
hsa-mir-766-5p
;
hsa-mir-873-5p
;
hsa-mir-205-3p
;
hsa-mir-141-5p
;
hsa-mir-6891-5p
;
hsa-mir-3173-3p
;
hsa-mir-7111-5p
;
hsa-mir-548l
;
hsa-mir-6870-5p
;
hsa-mir-5698
;
hsa-mir-4723-5p
;
hsa-mir-6825-5p
;
hsa-mir-7106-5p
;
hsa-mir-6797-5p
;
hsa-mir-1249-5p
;
hsa-mir-765
;
hsa-mir-6133
;
hsa-mir-6130
;
hsa-mir-6129
;
hsa-mir-6127
;
hsa-mir-4510
;
hsa-mir-4419a
;
hsa-mir-6727-3p
;
hsa-mir-4722-3p
;
hsa-mir-6752-3p
;
hsa-mir-6794-5p
;
hsa-mir-4716-3p
;
hsa-mir-4756-5p
;
hsa-mir-4739
;
hsa-mir-1321
;
hsa-mir-4779
;
hsa-mir-6856-5p
;
hsa-mir-6758-5p
;
hsa-mir-5006-3p
;
hsa-mir-4755-5p
;
hsa-mir-3692-3p
;
hsa-mir-29b-2-5p
;
hsa-mir-211-5p
;
hsa-mir-204-5p
;
hsa-mir-623
;
hsa-mir-642b-5p
;
hsa-mir-6070
;
hsa-mir-671-3p
;
hsa-mir-5088-3p
;
hsa-mir-4453
;
hsa-mir-4538
;
hsa-mir-3157-5p
;
hsa-mir-330-5p
;
hsa-mir-326
;
hsa-mir-4691-3p
;
hsa-mir-1306-5p
;
hsa-mir-6873-3p
;
hsa-mir-6817-3p
;
hsa-mir-7110-3p
;
hsa-mir-520f-5p
;
hsa-mir-6769b-3p
;
hsa-mir-4723-3p
;
hsa-mir-3183
;
hsa-mir-6800-3p
;
hsa-mir-6853-3p
;
hsa-mir-1206
;
hsa-mir-567
Nearest miRNA
hsa-mir-378d-1/Upstream/74401; hsa-mir-12113/Downstream/75103;
Nearest TSS
ENST00000502981/Upstream/3027;
ENST00000505529/Downstream/11353;
Nearest CpG islands
None/Target,
chr4-CpG: 46/Upstream/191185
,
chr4-CpG: 45/Downstream/96890
Upstream sequence
TAAACAACTCATGATAACAATAACAACAGATGTGGTAAATTAATGACTTCCAAAGAACATTTGCCTGAAATTGCTTGTTTTTTTTTTCTTTGATTCATCT
Downstream sequence
GGCTCAGCTTCAGCAGAAGATTCTTAGAGGGAAAGGCCTGTACTCACTGCAGCTCTGATGGCTCCACTTTGGAGGGAGAGCCTTCAGGGATGCTCTGCGG
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Sample Information
×
Sample name
P171D
Sample type
Nontumor
Gender
Female
CpG Island Information
×
Download
Curate